HOME >> MEDICINE >> NEWS
GroPep awarded key patent for infertility treatment in Europe

Adelaide biotechnology company, GroPep, has achieved a major development milestone in its infertility drug program with the granting of European patent number 1028743.

The patent covering GroPep's drug for the treatment of recurrent miscarriage provides the company with a European market patent exclusivity until at least 2018. GroPep already has two US patents covering the active ingredient of the drug until 2020.

According to the American College of Obstetricians and Gynecologists, at least 50 percent of recurrent miscarriages have no apparent explanation and there is no cure. The size of the market, the lack of competition and the strong patent position held by GroPep, means that the drug has the potential to participate in a market worth up to US$750 million annually.

Listed biopharmaceutical company GroPep Limited (ASX: GRO) today announced that European Patent No. 1028743, covering a method of treating recurrent miscarriage and preeclampsia using GroPep's infertility drug product - PV903, has been granted.

This patent grant is a major product development milestone as it provides the Company with a European market patent exclusivity until at least 2018. The European patent compliments two granted US patents licensed to GroPep by OSI Pharmaceuticals that cover the active ingredient of PV903 and method of manufacture until at least 2020. The combination provides GroPep with patent protection in the world's most valuable markets. The Company is also prosecuting additional patent applications to further extend the patent protection around PV903.

GroPep's Chief Executive Officer, Mr Bob Finder, said that the Company is developing PV903 as a potential treatment for recurrent miscarriage, a traumatic infertility condition with an estimated market potential of over US$750 million per year. There are currently no drugs approved for the treatment of recurrent miscarriage.

The European patent is owned by the Univers
'"/>

Contact: Tony Mitchell
61-88-354-7700
Research Australia
26-Jul-2006


Page: 1 2

Related medicine news :

1. GroPep starts Phase 1 infertility trial
2. GroPep completes final milestone of the path malaria vaccine initiative
3. GroPep to pursue promising asthma drug following preclinical study results
4. GroPep licenses technology to TGR BioSciences
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
7. LSUHSC awarded designation resulting in improved patient safety and outcomes
8. Scripps Research awarded $17 million for adult stem cell use to treat eye diseases
9. UIC awarded $7M NIH grant for infertility research
10. $2.6M grant awarded to New York University College of Nursing
11. Greenberg Prize awarded to Dr. Joseph G. Hayes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran Gill is ... surgery of the face, breast, and body. In 2018, she founded Aesthetics in ... surgery and aesthetic practice in Southwest Florida. Dr. Gill and her team offer ...
(Date:8/31/2020)... ... 31, 2020 , ... Ocean Springs, Mississippi-based pharmaceutical distributor Gulf ... responders across the United States. Since the start of the global COVID-19 pandemic, ... medical centers , hospitals , firefighters , and public schools ...
(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has over ... autism and other developmental disabilities, as well as supporting staff in caring for ... autism, school consultation, and staff development. She joined the company in 2015 as ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT ... help treat patients with respiratory conditions, including COVID-19, while reducing the need for ... but it captures exhaled gas and scrubs it free of carbon dioxide in ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... 31, 2020 , ... Cloudticity announced today that Network Products ... winner in the 15th Annual 2020 Network PG’s IT World Awards®. , The ... Network Products Guide honoring achievements of world’s best in organizational performance, product and ...
(Date:8/27/2020)... , ... August 27, 2020 , ... ... software, today announced the successful completion of their 2020 System and Organizational Controls ... their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect their long-standing ...
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, the ... leading provider of cloud CRM, marketing automation, and contact center solutions for senior ... the integration of Trella’s performance intelligence data and insights into Enquire’s CRM solution ...
Breaking Medicine Technology:
Cached News: